Reimportation Should Await Track/Trace Technology, HIGPA White Paper Says
Executive Summary
Providers interested in acquiring pharmaceuticals from outside the U.S. should first concentrate on advocacy for stronger anti-counterfeiting protections, the Health Industry Group Purchasing Association recommends in a product sourcing "white paper.
You may also be interested in...
FDA Developing Predictive Database To Help Screen Rx Imports
FDA is working with the New Mexico State University Physical Sciences Lab to develop a predictive database to help allocate resources for intercepting prescription drug imports
FDA Developing Predictive Database To Help Screen Rx Imports
FDA is working with the New Mexico State University Physical Sciences Lab to develop a predictive database to help allocate resources for intercepting prescription drug imports
Rx Import Law Likely In ‘04, AARP’s Rother Says; FDA Thinks States Will Wait
Congress will pass prescription drug importation legislation in 2004 as a "bridge" to the Medicare drug benefit in 2006, AARP Policy & Strategy Director John Rother predicted during a Kaiser Family Foundation webcast Dec. 2